AstraZeneca Annual Report and Financial Statements Form 20-F Information 2003 107 33 Statutory and other information 2003 2002 2001 $m $m $m Audit fees KPMG Audit Plc and its associates Audit services 5.4 3.5 2.5 Further assurance services 2.1 1.5 1.8 Taxation services 1.8 1.8 2.1 Other services 0.2 1.3 9.3 7.0 7.7 Audit fees others 0.1 0.1 9.3 7.1 7.8 Audit services include $4.9m for the audit of the Group, of which $1,600 is in respect of the parent company 2002 $1,600, 2001 $1,600, and a further $0.5m for other services required by statute or regulation.
Fees for further assurance services include employee pension fund and other benefit plan audit services together with control reviews associated with new systems implementations.
Taxation services consist of tax compliance services and tax advice.
Other services in prior years consist principally of consulting projects and support.
$0.5m 2002 $0.4m, 2001 $3.2m of the total fees for further assurance, taxation and other services were charged in the UK.
Related party transactions The Group had no material related party transactions which might reasonably be expected to influence decisions made by the users of these Financial Statements.
Subsequent events No significant change has occurred since the date of the annual Financial Statements.
